| PPARγ is an E3 ligase that induces the degradation of NFκB/p65 Y Hou, F Moreau, K Chadee Nature communications 3 (1), 1300, 2012 | 320 | 2012 |
| PD-L1 degradation pathway and immunotherapy for cancer Q Gou, C Dong, H Xu, B Khan, J Jin, Q Liu, J Shi, Y Hou Cell death & disease 11 (11), 955, 2020 | 244 | 2020 |
| Protective effect of Ligusticum chuanxiong and Angelica sinensis on endothelial cell damage induced by hydrogen peroxide YZ Hou, GR Zhao, J Yang, YJ Yuan, GG Zhu, R Hiltunen Life Sciences 75 (14), 1775-1786, 2004 | 150 | 2004 |
| Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II YZ Hou, J Yang, GR Zhao, YJ Yuan European journal of pharmacology 499 (1-2), 85-90, 2004 | 142 | 2004 |
| CD47/SIRPα pathway mediates cancer immune escape and immunotherapy X Jia, B Yan, X Tian, Q Liu, J Jin, J Shi, Y Hou International journal of biological sciences 17 (13), 3281, 2021 | 114 | 2021 |
| Entamoeba histolytica cysteine proteinase 5 binds integrin on colonic cells and stimulates NFκB-mediated pro-inflammatory responses Y Hou, L Mortimer, K Chadee Journal of Biological Chemistry 285 (46), 35497-35504, 2010 | 108 | 2010 |
| Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy Q Gou, X Gong, J Jin, J Shi, Y Hou Oncotarget 8 (36), 60704, 2017 | 106 | 2017 |
| Role of ferroptosis on tumor progression and immunotherapy D Gong, M Chen, Y Wang, J Shi, Y Hou Cell death discovery 8 (1), 427, 2022 | 75 | 2022 |
| Calcium homeostasis disruption-a bridge connecting cadmium-induced apoptosis, autophagy and tumorigenesis X Zhou, W Hao, H Shi, Y Hou, Q Xu Oncology Research and Treatment 38 (6), 311-315, 2015 | 75 | 2015 |
| Inhibition of rat vascular smooth muscle cell proliferation by extract of Ligusticum chuanxiong and Angelica sinensis YZ Hou, GR Zhao, YJ Yuan, GG Zhu, R Hiltunen Journal of Ethnopharmacology 100 (1-2), 140-144, 2005 | 63 | 2005 |
| PPARγ E3 ubiquitin ligase regulates MUC1-C oncoprotein stability Y Hou, J Gao, H Xu, Y Xu, Z Zhang, Q Xu, C Zhang Oncogene 33 (49), 5619-5625, 2014 | 60 | 2014 |
| Bcl2 impedes DNA mismatch repair by directly regulating the hMSH2-hMSH6 heterodimeric complex Y Hou, F Gao, Q Wang, J Zhao, T Flagg, Y Zhang, X Deng Journal of Biological Chemistry 282 (12), 9279-9287, 2007 | 58 | 2007 |
| Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation Y Hou, Z Zhang, Q Xu, H Wang, Y Xu, K Chen Oncogene 33 (15), 1997-2003, 2014 | 57 | 2014 |
| Role of autophagy on cancer immune escape Y Duan, X Tian, Q Liu, J Jin, J Shi, Y Hou Cell Communication and Signaling 19, 1-12, 2021 | 56 | 2021 |
| Ferulic acid inhibits endothelial cell proliferation through NO down‐regulating ERK1/2 pathway YZ Hou, J Yang, GR Zhao, YJ Yuan Journal of cellular biochemistry 93 (6), 1203-1209, 2004 | 54 | 2004 |
| PPARγ against tumors by different signaling pathways Z Zhang, Y Xu, Q Xu, Y Hou Onkologie 36 (10), 598-601, 2013 | 49 | 2013 |
| PPARα induces cell apoptosis by destructing Bcl2 J Gao, Q Liu, Y Xu, X Gong, R Zhang, C Zhou, Z Su, J Jin, H Shi, J Shi, ... Oncotarget 6 (42), 44635, 2015 | 45 | 2015 |
| Ubiquitin-mediated NFκB degradation pathway H Xu, M You, H Shi, Y Hou Cellular & Molecular Immunology 12 (6), 653-655, 2015 | 41 | 2015 |
| PPARδ promotes tumor progression via activation of Glut1 and SLC1-A5 transcription W Zhang, Y Xu, Q Xu, H Shi, J Shi, Y Hou Carcinogenesis 38 (7), 748-755, 2017 | 37 | 2017 |
| PPARδ signaling regulates colorectal cancer M You, S Yuan, J Shi, Y Hou Current pharmaceutical design 21 (21), 2956-2959, 2015 | 37 | 2015 |
